| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44000004 | HTLV-1 | ENSG00000168539.4 | protein_coding | CHRM1 | No | No | 1128 | P11229 Q53XZ3 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | CHRM1 |
|---|---|
| DrugBank ID | DB00805 |
| Drug Name | Minaprine |
| Target ID | BE0000092 |
| UniProt ID | P11229 |
| Regulation Type | agonist |
| PubMed IDs | 18045214; 2586634 |
| Citations | Duarte CD, Barreiro EJ, Fraga CA: Privileged structures: a useful concept for the rational design of new lead drug candidates. Mini Rev Med Chem. 2007 Nov;7(11):1108-19.@@Worms P, Kan JP, Steinberg R, Terranova JP, Perio A, Biziere K: Cholinomimetic activities of minaprine. Naunyn Schmiedebergs Arch Pharmacol. 1989 Oct;340(4):411-8. |
| Groups | Approved |
| Direct Classification | Phenylpyridazines |
| SMILES | CC1=CC(=NN=C1NCCN1CCOCC1)C1=CC=CC=C1 |
| Pathways | |
| PharmGKB | PA164748351 |
| ChEMBL | CHEMBL278819 |
